Bente Lund

Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer

Antonio González-Martı́n, Bhavana Pothuri, Ignace Vergote et al. · New England Journal of Medicine · 2019 · 2.3K citations · Full text

Medicine, Oncology, Pharmacology +15

Carbon and nitrogen cycling within the Bering/Chukchi Seas: Source regions for organic matter effecting AOU demands of the Arctic Ocean

John J. Walsh, C. Peter McRoy, L.K. Coachman et al. · Progress In Oceanography · 1989 · 411 citations

Natural Sciences, Marine Sciences, Oceanography +17

Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study

Robert L. Coleman, Domenica Lorusso, Christine Gennigens et al. · The Lancet Oncology · 2021 · 394 citations

Medicine, Oncology, Pharmacotherapy +13

Niraparib plus bevacizumab versus niraparib alone for platinum-sensitive recurrent ovarian cancer (NSGO-AVANOVA2/ENGOT-ov24): a randomised, phase 2, superiority trial

Mansoor Raza Mirza, Elisabeth Åvall Lundqvist, Michael J. Birrer et al. · The Lancet Oncology · 2019 · 246 citations

Medicine, Gynecology, Oncology +16

Niraparib Maintenance Therapy in Patients With Recurrent Ovarian Cancer After a Partial Response to the Last Platinum-Based Chemotherapy in the ENGOT-OV16/NOVA Trial

Josep M. del Campo, Ursula A. Matulonis, Susanne Malander et al. · Journal of Clinical Oncology · 2019 · 190 citations · Full text

Medicine, Oncology, Pharmacology +15